3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Glioma
3
Wilms Tumor
2
Urinary Bladder Neoplasms
2
Thyroid Neoplasms
2
Stomach Neoplasms
2
Sarcoma, Ewing
2
Sarcoma
2
Rhabdomyosarcoma
2
Rhabdoid Tumor
2
Pancreatic Neoplasms
2
Ovarian Neoplasms
2
Osteosarcoma
2
Neuroectodermal Tumors, Primitive, Peripheral
2
Neuroblastoma
2
Melanoma
2
Medulloblastoma
2
Lymphoma, Non-Hodgkin
2
Histiocytosis, Langerhans-Cell
2
Hepatoblastoma
2
Esophageal Neoplasms
2
Ependymoma
2
Colorectal Neoplasms
2
Carcinoma, Hepatocellular
2
Xanthogranuloma, Juvenile
1
Uterine Neoplasms
1
Uterine Cervical Neoplasms
1
Rectal Neoplasms
1
Prostatic Neoplasms
1
Multiple Myeloma
1
Lymphoma
1
Interventions
pembrolizumab
2
tislelizumab
1
sacituzumab govitecan
1
fludarabine
1
SYS6006 COVID-19 vaccine
1
Pemetrexed
1
Oxaliplatin
1
Leucovorin
1
Fluorouracil
1
Drug Therapy
1
Cetuximab
1
Carboplatin
1
Antiemetics
1
4-amino-5-fluoro-3-(5-(4-methylpiperazin-1-yl)-1H-benzimidazol-2-yl)quinolin-2(1H)-one
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Advanced Solid Tumors
×
ulixertinib
×
30 days
×
Clear all
No trials found.